Works matching IS 18696953 AND DT 2017 AND VI 8 AND IP 2

Results: 20

Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 309, doi. 10.1007/s13300-017-0227-x

By:

Feng, Xiaomeng;
Gao, Xia;
Jia, Yumei;
Zhang, Heng;
Xu, Yuan

Publication type:

Article

Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study.

Published in:

2017

By:

Suzuki, Kunihiro;
Aoki, Chie;
Kato, Kanako;
Shimizu, Masanori;
Sakurai, Shintaro;
Yanagi, Kazunori;
Kuroda, Hisamoto;
Aso, Yoshimasa

Publication type:

Report

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol).

Published in:

2017

By:

McGovern, Andrew;
Feher, Michael;
Munro, Neil;
Lusignan, Simon

Publication type:

Report

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 321, doi. 10.1007/s13300-017-0230-2

By:

Qin, Lei;
Chen, Stephanie;
Flood, Emuella;
Shaunik, Alka;
Romero, Beverly;
Cruz, Marie;
Alvarez, Cynthia;
Grandy, Susan

Publication type:

Article

Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.

Published in:

2017

By:

Gilbert, Richard;
Mende, Christian;
Vijapurkar, Ujjwala;
Sha, Sue;
Davies, Michael;
Desai, Mehul

Publication type:

Report

Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 227, doi. 10.1007/s13300-017-0233-z

By:

Almansour, Hadi;
Chaar, Betty;
Saini, Bandana

Publication type:

Article

Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 377, doi. 10.1007/s13300-017-0234-y

By:

Sofra, Daniela

Publication type:

Article

Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 213, doi. 10.1007/s13300-017-0235-x

By:

Kalra, Sanjay

Publication type:

Article

Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 275, doi. 10.1007/s13300-017-0236-9

By:

Evans, Marc;
Chubb, Barrie;
Gundgaard, Jens

Publication type:

Article

Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 335, doi. 10.1007/s13300-017-0237-8

By:

Qin, Lei;
Chen, Stephanie;
Flood, Emuella;
Shaunik, Alka;
Romero, Beverly;
Cruz, Marie;
Alvarez, Cynthia;
Grandy, Susan

Publication type:

Article

A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 385, doi. 10.1007/s13300-017-0238-7

By:

Nishimura, Akiko;
Harashima, Shin-ichi;
Fukushige, Haruna;
Wang, Yu;
Liu, Yanyan;
Hosoda, Kiminori;
Inagaki, Nobuya

Publication type:

Article

Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 401, doi. 10.1007/s13300-017-0239-6

By:

Mezquita-Raya, Pedro;
Ramírez de Arellano, Antonio;
Kragh, Nana;
Vega-Hernandez, Gabriela;
Pöhlmann, Johannes;
Valentine, William;
Hunt, Barnaby

Publication type:

Article

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 209, doi. 10.1007/s13300-017-0240-0

By:

Chatziralli, Irini

Publication type:

Article

Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 417, doi. 10.1007/s13300-017-0241-z

By:

Feher, Michael;
Vega-Hernandez, Gabriela;
Mocevic, Emina;
Buysse, Brian;
Myland, Melissa;
Power, Geraldine;
Nystrup Husemoen, Lise;
Kim, Joseph;
Witte, Daniel

Publication type:

Article

Errors in the Administration Technique of Insulin Pen Devices: A Result of Insufficient Education.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 221, doi. 10.1007/s13300-017-0242-y

By:

Truong, Teresa;
Nguyen, Trang;
Armor, Becky;
Farley, Jamie

Publication type:

Article

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 251, doi. 10.1007/s13300-017-0245-8

By:

Kay, Stephen;
Strickson, Amanda;
Puelles, Jorge;
Selby, Ross;
Benson, Eugene;
Tolley, Keith

Publication type:

Article

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 365, doi. 10.1007/s13300-017-0254-7

By:

McGovern, Andrew;
Feher, Michael;
Munro, Neil;
Lusignan, Simon

Publication type:

Article

Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes.

Published in:

2017

By:

Kalra, Sanjay

Publication type:

Erratum

Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 293, doi. 10.1007/s13300-017-0226-y

By:

Zhang, Xiuying;
Fang, Zhiwei;
Zhang, Chunfang;
Xia, Huihua;
Jie, Zhuye;
Han, Xueyao;
Chen, Yingli;
Ji, Linong

Publication type:

Article

PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study.

Published in:

Diabetes Therapy, 2017, v. 8, n. 2, p. 433, doi. 10.1007/s13300-017-0257-4

By:

Feng, Xiaomeng;
Gao, Xia;
Jia, Yumei;
Xu, Yuan

Publication type:

Article